Chemoinformaics analysis of 2(3H)-Benzofuranone, 3,3-dimethyl-
| Molecular Weight | 162.188 | nRot | 0 |
| Heavy Atom Molecular Weight | 152.108 | nRig | 11 |
| Exact Molecular Weight | 162.068 | nRing | 2 |
| Solubility: LogS | -3.047 | nHRing | 1 |
| Solubility: LogP | 2.674 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 22 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 1 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 6 |
| nHA | 2 | APOL | 24.9719 |
| nHD | 0 | BPOL | 12.6361 |
| QED | 0.43 |
| Synth | 2.348 |
| Natural Product Likeliness | 0.971 |
| NR-PPAR-gamma | 0.324 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.01 |
| Pgp-sub | 0.003 |
| HIA | 0.006 |
| CACO-2 | -4.61 |
| MDCK | 0.0000334 |
| BBB | 0.393 |
| PPB | 0.863015 |
| VDSS | 0.346 |
| FU | 0.220542 |
| CYP1A2-inh | 0.961 |
| CYP1A2-sub | 0.516 |
| CYP2c19-inh | 0.824 |
| CYP2c19-sub | 0.788 |
| CYP2c9-inh | 0.322 |
| CYP2c9-sub | 0.691 |
| CYP2d6-inh | 0.015 |
| CYP2d6-sub | 0.554 |
| CYP3a4-inh | 0.035 |
| CYP3a4-sub | 0.409 |
| CL | 4.172 |
| T12 | 0.348 |
| hERG | 0.005 |
| Ames | 0.055 |
| ROA | 0.108 |
| SkinSen | 0.864 |
| Carcinogencity | 0.805 |
| EI | 0.911 |
| Respiratory | 0.243 |
| NR-Aromatase | 0.027 |
| Antiviral | No |
| Prediction | 0.871106 |